Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis
- PMID: 33565601
- DOI: 10.14670/HH-18-309
Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis
Abstract
Gastric cancer (GC) is the fifth most common cancer and the third cause of cancer-related deaths worldwide. In western countries, more than half of GC patients are diagnosed at advanced stages and 5-year survival rates range between 20-30%. The only curative treatment is surgery, and despite recent advances in oncological therapies, GC prognosis is still poor. The main prognostic tool for patient categorization and treatment selection is the TNM classification, but its limitations are being increasingly recognized. Early recurrences may occur in early-stage disease, and patients at the same stage show heterogeneous outcomes. Thus, there is a need to improve GC stratification and to identify new prognostic factors, which may allow us to select drug-susceptible populations, refine patient grouping for clinical trials and discover new therapeutic targets. Molecular classifications have been developed, but they have not been translated to the clinical practice. On the other hand, histological assessment is cheap and widely available, and it is still a mainstay in the era of molecular medicine. Furthermore, histological features are acquiring new roles as reflectors of the genotype-phenotype correlation, and their potential impact on patient management is currently being analyzed. The aim of this literature review is to provide a modern overview of the histological assessment of GC. In this study, we discuss recent topics on the histological diagnosis of GC, focusing on the current role of Laurén classification and the potential value of new histological features in GC, such as inflammatory infiltration and tumor budding.
Similar articles
-
Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer.World J Gastrointest Oncol. 2022 Jun 15;14(6):1162-1174. doi: 10.4251/wjgo.v14.i6.1162. World J Gastrointest Oncol. 2022. PMID: 35949214 Free PMC article.
-
Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.Pathobiology. 2018;85(1-2):50-63. doi: 10.1159/000473881. Epub 2017 Jun 16. Pathobiology. 2018. PMID: 28618420
-
Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.Ann Diagn Pathol. 2021 Feb;50:151677. doi: 10.1016/j.anndiagpath.2020.151677. Epub 2020 Dec 7. Ann Diagn Pathol. 2021. PMID: 33310591
-
Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.Dan Med J. 2012 Dec;59(12):B4568. Dan Med J. 2012. PMID: 23290296 Review.
-
[Update on gastric cancer. New molecular classifications].Rev Esp Patol. 2021 Apr-Jun;54(2):102-113. doi: 10.1016/j.patol.2020.06.002. Epub 2020 Jul 24. Rev Esp Patol. 2021. PMID: 33726886 Review. Spanish.
Cited by
-
Hereditary Gastrointestinal Tumor Syndromes: When Risk Comes with Your Genes.Curr Issues Mol Biol. 2024 Jun 26;46(7):6440-6471. doi: 10.3390/cimb46070385. Curr Issues Mol Biol. 2024. PMID: 39057027 Free PMC article. Review.
-
Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer.World J Gastrointest Oncol. 2022 Jun 15;14(6):1162-1174. doi: 10.4251/wjgo.v14.i6.1162. World J Gastrointest Oncol. 2022. PMID: 35949214 Free PMC article.
-
Prognostic significance of tumor budding, desmoplastic reaction, and lymphocytic infiltration in patients with gastric adenocarcinoma.World J Gastrointest Pathophysiol. 2024 Apr 22;15(1):91237. doi: 10.4291/wjgp.v15.i1.91237. World J Gastrointest Pathophysiol. 2024. PMID: 38682027 Free PMC article.
-
Self-Renewal and Cancers of the Gastric Epithelium: An Update and the Role of the Lectin TFF1 as an Antral Tumor Suppressor.Int J Mol Sci. 2022 May 11;23(10):5377. doi: 10.3390/ijms23105377. Int J Mol Sci. 2022. PMID: 35628183 Free PMC article. Review.
-
Tumor budding in gastric cancer.World J Gastrointest Surg. 2023 Apr 27;15(4):578-591. doi: 10.4240/wjgs.v15.i4.578. World J Gastrointest Surg. 2023. PMID: 37206064 Free PMC article. Review.
References
-
- Ajani J.A., Rodriguez W., Bodoky G., Moiseyenko V., Lichinitser M., Gorbunova V., Vynnychenko I., Garin A., Lang I. and Falcon S. (2010). Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: The FLAGS trial. J. Clin. Oncol. 28, 1547-1553. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous